Navigation Links
Study finds statin costs 400 percent higher in US compared to UK
Date:1/5/2012

(Boston) -- In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance is approximately 400 percent higher than comparable costs paid by the government in the United Kingdom (U.K.). These findings, from the Boston University School of Medicine (BUSM) Boston Collaborative Drug Surveillance Program, are the first results of a comprehensive comparison of prescription drug costs between the U.S. and U.K. The study appears on-line in the journal Pharmacotherapy.

Expenditures for prescription drugs remain a large part of the ongoing debate on the costs of medical care in the U.S. and U.K. Because of the many complex and interactive variables that contribute to these costs, well-defined estimates of the actual and relative usage and costs for the two countries have not been reliably documented.

Data for this study came from two large electronic medical databases, one in each country. Costs were derived from private health insurance claims in the U.S., while the costs were originated from a general practice research database constructed in 1990 in the U.K.

The study is based upon a 2005 sample of 280,000 people age 55-64 in each country. Statins were prescribed to an estimated 32.7 percent of people in the U.S. and 24.4 percent in the U.K. In the U.S. the estimated annual cost of statins ranged from a high of $1,428 for simvastatin (generic unavailable), to a low of $314 for lovastatin (available in generic formulation). In the U.K. the annual cost varied from a high of $500 for atorvastatin (generic not available), to a low of $164 for simvastatin (available in generic). The estimated cost per pill was at least twice as high for each statin prescribed in both countries.

When the annual cost for each annual statin user together with the number of users were combined, the total estimated cost for statin users was $69.5 million in people covered by private insurance companies in the U.S. The total estimated annual cost for statin users covered by the government in the U.K. was $15.7 million.

"In addition to differences in overall statin use and per unit costs, another significant factor contributing to the disparity of costs appears to be the availability and utilization of generics," said lead author Hershel Jick, MD, Director Emeritus of BUSM's Collaborative Drug Surveillance Program and associate professor of medicine at BUSM.

According to the researchers, simvastin was approved in the U.S. for sale in generic formulation in late June 2006. Accordingly, within the next six months more than 60 percent of users switched from the brand preparation to the generic. The resultant estimated cost was reduced more than 60 percent. According to the researchers, however, it still was four times higher than that in the U.K.


'/>"/>
Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Drug Eases Gout Flare-ups in Some Patients: Study
2. Study Reveals Whos More Prone to Be a Mean Drunk
3. Kaiser Permanente study finds continuous health coverage essential for patients managing diabetes
4. Safety-First Playgrounds Linked to Bored, Inactive Kids: Study
5. U-M study shows updated rotavirus vaccine not linked to increase in bowel obstruction
6. U.S. Heart Attack Patients Readmitted Most Often: Study
7. Nap-deprived tots may be missing out on more than sleep, says University of Colorado-led study
8. Womens Sexual Satisfaction Often Rises With Age: Study
9. BINGO! game helps researchers study perception deficits
10. Genetic predisposition to disease common in 2 supercentenarians: New study
11. Study Looks at Deep Brain Stimulation in Bipolar Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , ... February 24, 2017 , ... ... newly designed TaskMate Go. Core benefits and advantages built into the home office ... stylish, functional look and feel. Ability to gain the benefits embedded in the ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. ... has officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ ... Erik Schanssema ’s true account of his paramedic experiences. Schanssema describes the tragedies he ... and his attempts to overcome them. , Schanssema, initially unsure of the career path ...
(Date:2/24/2017)... ... , ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently ... as the Chairman of the Management Committee when IFN was originally formed in 2002 ... of investor/owners and development of the business plan. He became the first paid ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning ... Gran Fondo of Marin. For the second year in a row, cyclists will ... , “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 23, 2017 Report analyzes the worldwide markets ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year ... analytics are derived from primary and secondary research. Company profiles ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
(Date:2/23/2017)... 23, 2017 Visiomed, the French leader ... 1997, is changing the landscape of healthcare with ... with pro-active, custom-made solutions. Recognizing the rising demand ... affordable healthcare without walls, Visiomed has launched BewellConnect, ... with healthcare professionals that is empowering the lives ...
Breaking Medicine Technology: